Fatal primary cutaneous zygomycosis caused by Saksenaea vasiformis: Case report and review of literature

Surgical Infections

Volumn 13, Issue 2, 2012, Pages 125-129

  Kaushik, Robin ^a   Chander, Jagdish ^a   Gupta, Sanjay ^a   Sharma, Rajeev ^a   Punia, Rajpal Singh ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; CREATININE; POTASSIUM;

ADULT; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; CASE REPORT; CUTANEOUS ZYGOMYCOSIS; DRUG DOSE INCREASE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MICROBIOLOGY; MOLECULAR DIAGNOSIS; MUCORALES; MULTIPLE ORGAN FAILURE; NECROTIZING FASCIITIS; PATIENT MONITORING; PRIORITY JOURNAL; REVIEW; SAKSENAEA VASIFORMIS; SEPSIS; SKIN INFECTION; SURGICAL INFECTION; ZYGOMYCOSIS;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DEBRIDEMENT; DELAYED DIAGNOSIS; DERMATOMYCOSES; FATAL OUTCOME; FEMALE; HUMANS; INJECTIONS, INTRAMUSCULAR; MIDDLE AGED; MUCORMYCOSIS;

EID: 84859624274     PISSN: 10962964     EISSN: 15578674     Source Type: Journal    
DOI: 10.1089/sur.2010.078     Document Type: Review

References (26)

1. Prabhu RM, Patel R. Mucormycosis and entomophthoramycosis: A review of the clinical manifestations diagnosis and treatment. Clin Microbiol Infect 2004;10:31-47.
2. Gupta KL, Joshi K, Sud K, et al. Renal zygomycosis: An under-diagnosed cause of acute renal failure. Nephrol Dial Transplant 1999;14:2720-2725.
3. Ajello L, Dean DF, Irwin RS. The zygomycete Saksenaea vasiformis as a pathogen of humans with a critical review of the etiology of zygomycosis. Mycologia 1976;68: 52-62.
4. Al-Hedaithy M. Cutaneous zygomycosis due to Saksenaea vasiformis: Case report and literature review. Ann Saudi Med 1998;18:428-431.
5. Vega W, Orellana M, Zaror L, et al. Saksenaea vasiformis infections: Case report and literature review. Mycopathologia 2006;162:289-294.
6. Lechevalier P, Hermoso DG, Carol A, et al. Molecular diagnosis of Saksenaea vasiformis cutaneous infection after scorpion sting in an immunocompetent adolescent. J Clin Microbiol 2008;46:3169-3172.
7. Solano T, Atkins B, Tambosis E, et al. Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis 2000;30:942-943.
8. Aarset H, Aasarod K, Bergan U, Angelsen A. Acute renal infarction in a woman with slight asthma. Nephrol Dial Transplant 2001;16:1711-1712.
9. Upton A, Gabriel R, Fougere C, Rogers K. A patient with cutaneous zygomycosis due to Saksenaea vasiformis. Infect Dis Clin Pract 2002;11:137-139.
10. Padmaja, IJ, Ramani TV, Kalyani S. Cutaneous zygomycosis: Necrotising fasciitis due to Saksenaea vasiformis. Indian J Med Microbiol 2006;24:58-60.
11. Blanchet D, Dannaoui E, Fior A, et al. First case of Saksenaea vasiformis infection in French Guiana. Emerg Infect Dis 2008; 14:342-344.
12. Baradkar VP, Mathur M, Taklikar S, et al. Fatal rhino-orbitocerebral infection caused by Saksenaea vasiformis in an immunocompetent individual: First case report from India. Indian J Med Microbiol 2008;26:385-387.
13. Trotter DJ, Gonis G, Cottrill E, Coombs C. Disseminated Saksenaea vasiformis in an immunocompetent host. Med J Aust 2008;189:519-520.
14. Wilson PA. Zygomycosis due to Saksenaea vasiformis caused by a magpie peck. Med J Aust 2008;189:521-522.
15. Stewardson AJ, Holmes NE, Ellis DH, Howden BP. Cutaneous zygomycosis caused by Saksenaea vasiformis following water-related wound in a 24-year old immunocompetent woman. Mycoses 2009;52:547-549.
16. Kompoti M, Michalia M, Kallitsi G, et al. Fatal cutaneous Saksenaea vasiformis infection in a critically ill trauma patient. Mycoses 2011;54:e599-601.
17. Saksena SB. A new genus of the Mucorales. Mycologia 1953; 45:426-436.
18. Kaufman L, Padhye AA, Parker S. Rhinocerebral zygomycosis caused by Saksenaea vasiformis. J Med Vet Mycol 1988; 26:237-241.
19. Chakrabarti A, Kumar P, Padhye AA, et al. Primary cutaneous zygomycosis due to Saksenaea vasiformis and Apophysomyces elegans. Clin Infect Dis 1997;24:580-583.
20. Parker C, Kaminski G, Hill D. Zygomycosis in a tattoo, caused by Saksenaea vasiformis. Australas J Dermatol 1986; 27:107-111.
21. Spellberg B, Edwards J Jr, Ibrahim A. Novel perspectives on mucormycosis: Pathophysiology, presentation and management. Clin Microbiol Rev 2005;18:556-569.
22. Oberle AD, Penn RL. Nosocomial invasive Saksenaea vasiformis infection. Am J Clin Pathol 1983;80:885-888.
23. Bearer EA, Nelson PR, Chowers MY, Davis CE. Cutaneous zygomycosis caused by Saksenaea vasiformis in a diabetic patient. J Clin Microbiol 1994;32:1823-1824.
24. Patino JF, Mora R, Guzman MA, Rodriguez-Franco E. Mucormycosis: A fatal case by Saksenaea vasiformis. World J Surg 1984;8:419-422.
25. Alastruey-Izquierdo A, Castelli MV, Cuesta I, et al. In vitro activity of antifungals against Zygomycetes. Clin Microbiol Infect 2009;15:71-76.
26. Gómez-López A, Cuenca-Estrella M, Monzón A, Rodriguez- Tudela JL. In vitro susceptibility of clinical isolates of zygomycota to amphotericin B, flucytosine, itraconazole and voriconazole. J Antimicrob Chemother 2001;48:919-921.